<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-Senate" public-private="public">
	<form>
		<distribution-code display="yes">II</distribution-code>
		<congress>110th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>S. 2013</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20070803">August 3, 2007</action-date>
			<action-desc><sponsor name-id="S307">Mr. Brown</sponsor> (for himself
			 and <cosponsor name-id="S271">Mr. Voinovich</cosponsor>) introduced the
			 following bill; which was read twice and referred to the
			 <committee-name committee-id="SSFI00">Committee on
			 Finance</committee-name></action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To initially apply the required use of tamper-resistant
		  prescription pads under the Medicaid Program to schedule II narcotic drugs and
		  to delay the application of the requirement to other prescription drugs for 18
		  months.</official-title>
	</form>
	<legis-body>
		<section id="S1" section-type="section-one"><enum>1.</enum><header>Short
			 title</header><text display-inline="no-display-inline">This Act may be cited as
			 the <quote><short-title>Patient and Pharmacy Protection
			 Act of 2007</short-title></quote>.</text>
		</section><section id="id4AF992ECEAEF460BBE792EB718D9790D"><enum>2.</enum><header>Phased-in
			 requirement to use tamper-resistant prescription pads under Medicaid; initial
			 application to schedule II narcotic drugs</header><text display-inline="no-display-inline">Effective as if included in the enactment of
			 section 7002(b) of the U.S. Troop Readiness, Veterans' Care, Katrina Recovery,
			 and Iraq Accountability Appropriations Act, 2007 (Public Law 110–28), paragraph
			 (2) of such section is amended to read as follows:</text>
			<quoted-block display-inline="no-display-inline" id="id7C31020E41A14D668C0B1F24E7062EAA" style="OLC">
				<paragraph commented="no" display-inline="no-display-inline" id="idA888F4A407CE482396BA078975964ECE"><enum>(2)</enum><header>Phased-in
				application</header><text>The amendments made by paragraph (1) shall
				apply—</text>
					<subparagraph commented="no" display-inline="no-display-inline" id="id32B6AD83801B49ED9384C55562D09A0B"><enum>(A)</enum><text>with respect to
				covered outpatient drugs (as defined in section 1927(k)(2)) which are narcotic
				drugs included in schedule II of section 202 of the Controlled Substances Act
				(21 U.S.C. 812), to prescriptions for such drugs executed after September 30,
				2007; and</text>
					</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="idCF8AA9F1385F47E6A75E6FFDADF0472E"><enum>(B)</enum><text>with respect to
				any other covered outpatient drugs (as so defined), to prescriptions executed
				after March 31,
				2009.</text>
					</subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
		</section></legis-body>
</bill>
